Chemical Namearipiprazole lauroxil
Dosage FormExtended-release injectable suspension (intramuscular; 441 mg, 662 mg, 882 mg, 1064 mg)
Drug ClassAntipsychotics
CompanyAlkermes Inc
Approval Year2015


  • To treat adults with schizophrenia.
Last updated on 10/9/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Aristada (aripiprazole lauroxil) Prescribing Information2020Alkermes, Inc., Waltham, MA